VIVUS, Inc. (NASDAQ:VVUS) – Auxilium Pharmaceuticals, Inc. (NASDAQ:AUXL) Stendra Gets FDA Go-Ahead For 15 Minutes Prior Use

Boston, MA 09/19/2014 (wallstreetpr) – Stendra, the erectile dysfunction drug developed collaboratively by VIVUS, Inc. (NASDAQ:VVUS) and Auxilium Pharmaceuticals, Inc. (NASDAQ:AUXL) has been given the nod by the U.S. Food and Drug Administration to be used 15 minutes earlier. It is crucial to point out here that this drug was already approved by the FDA, […]

Auxilium Pharmaceuticals, Inc. (NASDAQ:AUXL) Adopts Shareholder-Rights Plan For Endo International plc – Ordinary Shares (NASDAQ:ENDP) Bid

Boston, MA 09/18/2014 (wallstreetpr) – Auxilium Pharmaceuticals, Inc. (NASDAQ:AUXL) confirmed yesterday that Endo International plc – Ordinary Shares (NASDAQ:ENDP) gave an unsolicited buyout offer for the acquisition of former. Meanwhile, Auxilium Pharmaceuticals has also adopted the shareholder rights plan. A lot of suitors The company had earlier agreed that it will merge with QLT Inc. […]

Endo International plc – Ordinary Shares (NASDAQ:ENDP) To Acquire Auxilium Pharmaceuticals, Inc. (NASDAQ:AUXL) In $1.4 Billion

Boston, MA 09/18/2014 (wallstreetpr) – According to reports, Endo International plc – Ordinary Shares (NASDAQ:ENDP) has decided to make an unsolicited offer of $1.4 billion to acquire Auxilium Pharmaceuticals, Inc. (NASDAQ:AUXL). On the basis of the offer made by ENDP, each share of AUXL is valued at $28.10, which is fair enough in regard with […]

Auxilium Pharmaceuticals, Inc. (NASDAQ:AUXL) Under Investigation Over Planned Merger

Boston, MA 07/01/2014 (wallstreetpr) – Investigators at Newman Ferrara have announced the investigation of Auxilium Pharmaceuticals, Inc. (NASDAQ:AUXL), a U.S. drug company that is planning to merge into a Canadian counterpart known as QLT Inc. (USA) (NASDAQ:QLTI). The investigators are concerned about whether the board of Auxilium acted fairly in entering and approving a deal […]